A dual-mode targeted Nanopore sequencing assay for comprehensive SMN1 and SMN2 variant analysis
Hall, B.; Yaslam, S.; Ramaswamy, S.; Sinha, S.; El Naofal, M.; Rabea, F.; Killinger, B.; Latham, G.; Abou Tayoun, A.
Show abstract
BackgroundSpinal Muscular Atrophy (SMA) is one of the most common recessive disorders for which several life-saving treatment options are currently available. It is essential to establish universal SMA screening and diagnostic programs using scalable, cost-effective and accessible platforms to accurately identify all variation types, which is complicated by homologous SMN1 and SMN2 genes. MethodsWe developed a dual-mode PCR-based target enrichment that generates 2.7 to 11.2 kb amplicons spanning SMN1 and SMN2 genes for any-length nanopore sequencing. We trained a variant calling model that utilizes paralog-specific sequences and read-depth data to accurately detect sequence and copy number variants specific to each gene. ResultsWe present results from the development, optimization, and external evaluation of this assay using over 750 samples, including cell lines, residual presumed normal blood donors, and patients with known SMN1 and SMN2 genotypes. The assay detects SNVs, indels, and CNVs with >98% accuracy across all sample sets, with a highly dynamic throughput range, relatively fast turnaround time, and limited hands-on-time. Together with the modest capital investment and consumable costs per sample, this assay can help increase access to SMA testing in low- and middle-income settings. ConclusionWe describe a PCR/Nanopore sequencing assay and a customized analysis pipeline for the comprehensive and accurate detection of variation at the SMA locus and demonstrate its scalability, cost-effectiveness, and potential for the universal implementation of SMA screening and diagnostic programs. Human GenesSMN1 survival of motor neuron 1, telomeric HGNC:11117 SMN2 survival of motor neuron 2, centromeric HGNC:11118 CFTR CF transmembrane conductance regulator HGNC:1884
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Genome-Wide Sequencing as a First-Tier Screening Test for Short Tandem Repeat Expansions 92%
- Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework 92%
- Evaluating Genome Sequencing Strategies: Trio, Singleton, and Standard Testing in Rare Disease Diagnosis 92%
Similar papers in this journal
- Optimised multiplex amplicon sequencing for mutation identification using the MinION nanopore sequencer 93%
- A novel high-throughput molecular counting method with single base-pair resolution enables accurate single-gene NIPT 93%
- Rapid detection of G6PD deficiency SNPs using a novel amplicon-based MinION Sequencing Assay 92%
Similar papers in this journal
- Reducing Sanger Confirmation Testing through False Positive Prediction Algorithms 94%
- One in seven pathogenic variants can be challenging to detect by NGS: An analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation 92%
- Distinct rates of VUS reclassification are observed when subclassifying VUS by evidence level 91%
Similar papers in this journal
- Using single molecule Molecular Inversion Probes as a cost-effective, high-throughput sequencing approach to target all genes and loci associated with macular diseases 92%
- Phasing of de novo mutations using a scaled-up multiple amplicon long-read sequencing approach 91%
- Functional Interrogation of Lynch Syndrome Associated MSH2 Missense Variants Using CRISPR-Cas9 Gene Editing in Human Embryonic Stem Cells 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.